SCHEMBL23763885

SCHEMBL23763885

CC1CC(CS)NC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23763881 0.75 — —
SCHEMBL10208353 0.75 — —
SCHEMBL10100208 0.75 — —
Hydrochloric Acid SCHEMBL3442737 0.73 FUCA1 (0.33) —
SCHEMBL19287539 0.73 — —
SCHEMBL19119942 0.73 — —
SCHEMBL1547867 0.68 CYP2C9 (0.30) —
SCHEMBL22175412 0.67 — —
SCHEMBL25597484 0.64 — —
SCHEMBL10854981 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3450433-B1 PURINE DERIVATIVES AS TLR7 INHIBITORS FOR TREATING E.G. SYSTEMIC LUPUS ERYTHEMATOSUS SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2021-08-18 — — EP disclosed
Send feedback